Ganzhou Hemay Pharmaceutical announced that, given current market conditions, it has decided to postpone its global offering and listing and to refund application monies.
The international underwriting agreement for the international offering will not be entered into, and as a result, the Hong Kong underwriting agreement for the Hong Kong public offering will not become unconditional.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments